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In Brief
Circulating effector cytotoxic T cells
recognize antigen and kill virus-infected
hepatocytes without need to migrate into
the tissue. Rather, they arrest within liver
sinusoids, docking onto platelets, from
where they probe hepatocytes for the
presence of antigens, a process that is
inhibited during liver fibrosis.
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Effector CD8+ T cells (CD8 TE) play a key role during
hepatotropic viral infections. Here,weusedadvanced
imaging in mouse models of hepatitis B virus
(HBV) pathogenesis to understand the mechanisms
whereby these cells home to the liver, recognize anti-
gens, and deploy effector functions. We show that
circulating CD8 TE arrest within liver sinusoids by
docking onto platelets previously adhered to sinusoi-
dal hyaluronan via CD44. After the initial arrest, CD8
TE actively crawl along liver sinusoids and probe
sub-sinusoidal hepatocytes for the presence of anti-
gens by extending cytoplasmic protrusions through
endothelial fenestrae.Hepatocellular antigen recogni-
tion triggers effector functions in a diapedesis-inde-
pendent manner and is inhibited by the processes
of sinusoidal defenestration and capillarization that
characterize liver fibrosis. These findings reveal the
dynamic behavior whereby CD8 TE control hepato-
tropic pathogens and suggest how liver fibrosismight
reduce CD8 TE immune surveillance toward infected
or transformed hepatocytes.
INTRODUCTION
The capacity of CD8+ T cells to protect against intracellular path-
ogens is mediated by antigen (Ag)-experienced effector cells
that migrate to infected organs, recognize pathogen-derived
Ags, and perform effector functions. Priming of adaptive immune
responses during infection with intracellular bacteria or viruses
results in extensive reprogramming of T cell trafficking so that
effector cells can deal with pathogens that are located in periph-
eral compartments (Masopust et al., 2001). Understanding of the
dynamic events leading to generation and expansion of effector486 Cell 161, 486–500, April 23, 2015 ª2015 Elsevier Inc.CD8+ T cells (CD8 TE) within lymphoid organs has rapidly
improved in recent years, particularly with the use of intravital mi-
croscopy (IVM) (Germain et al., 2012). By contrast, less is known
on the spatiotemporal aspects that govern CD8 TEmigration and
function at peripheral infection sites. As a general rule, CD8 TE
are thought to recognize pathogen-infected parenchymal cells
and perform effector functions in the brain, skin, or gut following
extravasation from post-capillary venules mediated by different
combinations of inflammation-regulated selectins, integrins,
and chemokines (Mueller, 2013).
The liver is a vital organ in which pathogenesis and outcome of
infection by clinically relevant noncytopathic viruses, such as
hepatitis B virus (HBV) or hepatitis C virus (HCV), is determined
by CD8 TE (Guidotti and Chisari, 2006). Several observations
suggest that the liver may be an exception to the classic multi-
step leukocyte migration paradigm involving rolling, adhesion,
and extravasation from postcapillary venules. First, leukocyte
adhesion is not restricted to the endothelium of post-capillary
venules and occurs also in sinusoids (Lee and Kubes, 2008).
Second, leukocyte adhesion to liver sinusoidal endothelial cells
(LSEC) often occurs independent of any notable rolling (Lee
and Kubes, 2008). Furthermore, in contrast to vascular beds in
most organs—where a continuous endothelial cell layer and a
basal membrane physically separate parenchymal cells from
circulating leukocytes—LSEC lack tight junctions as well as a
basal membrane and contain numerous fenestrae of up to
200 nm in diameter (Jacobs et al., 2010). Thus, the fenestrated
endothelial barrier of sinusoids provides the opportunity for
direct interaction of circulating cells with underlying hepato-
cytes. For all these reasons, the pathways directing the spatio-
temporal regulation of CD8 TE migration and function in the liver
may differ from those in other vascular districts.
Here, we have used advanced imaging methodologies in
mouse models of HBV pathogenesis to show that hepatic CD8
TE homing is indeed independent of selectins, b2- and a4-integ-
rins, PECAM-1, VAP-1, Gai-coupled chemokine receptors, or Ag
recognition, all previously thought to be variably relevant for
leukocyte trafficking in other organs (von Andrian and Mackay,
2000; Mueller, 2013). Rather, circulating CD8 TE initially arrest
within liver sinusoids by docking onto platelets in turn adherent
to sinusoidal hyaluronan via CD44. After the initial platelet-
dependent arrest, CD8 TE actively crawl along liver sinusoids
and extend cellular protrusions through endothelial fenestrae
to probe underlying hepatocytes for the presence of Ag. Hepato-
cellular Ag recognition leading to cytokine production and hepa-
tocyte killing occurs in a diapedesis-independent manner, i.e.,
before CD8 TE extravasation into the parenchyma, and it is in-
hibited by experimental sinusoidal defenestration and capillari-
zation, both of which are characteristic of liver fibrosis.
RESULTS
CD8 TE Arrest within Liver Sinusoids Independently of
Ag Recognition
To study howCD8 TE traffic within the liver and recognize Ag, we
made use of two transgenic mouse strains whose CD8+ T cells
express H2b- or H2d-restricted T cell receptors (TCRs) specific
for the HBV nucleocapsid (Cor) or envelope (Env) proteins,
respectively (Isogawa et al., 2013). Naive CD8+ T cells from these
TCR transgenic mice (referred to as Cor93 and Env28 CD8+
T cells, respectively) could be differentiated in vitro into bona
fide CD8 TE (data not shown) that, when transferred into HBV
replication-competent transgenic mice (Guidotti et al., 1995),
caused liver disease and inhibited viral replication (data not
shown) as much as previously reported polyclonal memory
HBV-specific CD8+ T cells (Iannacone et al., 2005). Further ana-
lyses in HBV replication-competent transgenic mice revealed
that (1) passively transferred Cor93 and Env28 CD8 TE accumu-
late at peak levels in the liver (seequantification of flowcytometric
data in Figure 1A) and no longer circulate throughout the hepatic
vasculature by 2 hr of intravenous injection (see quantification of
epifluorescence IVMdata in Figure 1B), and (2) virtually all CD8 TE
that arrested within the 2 hr time frame (30% of visualized CD8
TE, Figure 1C) adhered to hepatic sinusoids and not to post-
sinusoidal venules (Figures 1D and 1E; Movie S1). The transfer
of HBV-specific CD8 TE into wild-type (WT) mice, previously in-
jected with a reporter adenovirus (Ad-HBV-GFP) rendering
HBV-replicating hepatocytes fluorescent (Sprinzl et al., 2001), re-
vealed that CD8 TE adhere to liver sinusoids regardless of the
location of HBV Ag-producing hepatocytes (Movie S1). Consis-
tent with these results, the overall accumulation of CD8 TE in
the liver was independent of Ag recognition, as virtually identical
numbers of co-transferred Cor93 and Env28 CD8 TE were iso-
lated by 2 hr of injection from the same liver of transgenic and
nontransgenic MHC-matched and MHC-mismatched recipients
(Figure 1F; Movie S1).
Adhesion Molecules that Govern Leukocyte Trafficking
in Other Organs Are Not Required for CD8 TE
Accumulation in the Liver
Next, we investigated whether the hepatic CD8 TE accumulation
observed within 2 hr of transfer involves the same adhesion mol-
ecules known to govern leukocyte trafficking in vascular loca-
tions of other organs (von Andrian and Mackay, 2000). Blocking
PSGL-1, CD62L, CD62E, VLA-4, LFA-1, PECAM-1, and VAP-1expressed by CD8+ T cells or LSEC (data not shown) had no
impact on hepatic CD8 TE accumulation (Figures 2A–2C) and
neither did CD8 TE expression of CD44 (Figure 2D), which has
been implicated in hepatic neutrophil recruitment (McDonald
et al., 2008). Pertussis toxin (PTX) treatment of CD8 TE, which in-
hibited chemokine-mediated in vitro migration (data not shown),
also did not alter the in vivo hepatic homing capacity of these
cells (Figure 2E). Of note, the expression of selectins, integrin
ligands, and chemokines is relatively low in the liver of HBV repli-
cation-competent transgenic mice prior to CD8 TE transfer (Fig-
ures S1A and S1B), consistent with the uninflamed environment
seen in experimentally infected chimpanzees prior to HBV-spe-
cific CD8+ T cell arrival (Wieland and Chisari, 2005). Increasing
the hepatic expression of selectins, integrin ligands, and chemo-
kines via Env28 CD8 TE injection (Figures S1A and S1B) did not
affect the liver homing potential of subsequently injected Cor93
CD8 TE either PTX-treated or not (Figures 2F and 2G). To ascer-
tain that the results shown in Figure 2 were not limited to in vitro
differentiated CD8 TE, we verified that the liver homing potential
of in vivo generated CD8 TE isolated from the spleen of lympho-
cytic choriomeningitis virus (LCMV)-infected mice and injected
into recipient mice was not affected by blocking the above-
mentioned adhesion molecules, even when multiple ligand-re-
ceptor pairs where blocked at one time (Figures S1C–S1G).
Thus, hepatic accumulation of in vitro or in vivo differentiated
CD8 TE is independent of PSGL-1, CD62L, CD62E, VLA-4,
LFA-1, PECAM-1, VAP-1, their CD44 expression and Gai-
coupled receptor signaling capability, and the degree of liver
inflammation.
Hepatic CD8 TE Accumulation Requires Platelet
Adherence to Sinusoidal Hyaluronan via CD44
We previously showed that platelets facilitate the hepatic accu-
mulation of CD8 TE observed in HBV replication-competent mice
at 1–2 days post transfer (Iannacone et al., 2005). However, it re-
mained to be determined whether a platelet-specific pathway
could influence the early adhesion of CD8 TE to liver sinusoids.
To address this question, we crossed two transgenic mouse
strains, one HBV replication-competent and the other with
platelets in which the human glycoprotein (GP) Iba subunit
replaced the mouse homolog in the GPIb-IX-V complex (mGPI-
banull;hGPIbaTgmice) (Ware et al., 2000). The resulting HBV repli-
cation-competent mGPIbanull;hGPIbaTg mice can be depleted of
endogenous platelets by specific anti-hGPIba monoclonal anti-
bodies and subsequently reconstituted with mouse platelets
lacking reactivity with the depleting antibodies (Iannacone
et al., 2008). Platelet depletion per se reduced the hepatic accu-
mulation of CD8 TE by 50% by 2 hr after transfer (Figure 3A),
and this reduction was associated with diminished CD8 TE adhe-
sion to LSEC (Figure 3B; Movie S2) and higher number of CD8 TE
circulating throughout the liver microvasculature (Figure 3C;
Movie S2). Notably, platelets frequently adhered to LSEC prior
to CD8 TE transfer, forming small and transient aggregates of
up to 10–15 platelets (Movie S3). Although these aggregates
covered a minute fraction of the LSEC surface area (<3%, data
not shown), circulating CD8 TE docked preferentially to these
sites (Movie S3), so that up to 30% of intrasinusoidal CD8 TE
were found attached to platelets at the 2 hr time point by staticCell 161, 486–500, April 23, 2015 ª2015 Elsevier Inc. 487
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Figure 1. CD8 TE Arrest within Liver Sinusoids Independently of Ag Recognition
Cor93 (107) CD8 TE (red) and Env28 (10
7) CD8 TE (green) were intravenously injected into HBV replication-competent transgenic mice (H2
bxd) or into the indicated
mouse strains.
(A) Absolute number of hepatic Cor93 (red) and Env28 (green) CD8 TE recovered at the indicated time points after injection. n = 8; results are representative of
three independent experiments.
(B) Quantification of the number of circulating Cor93 (red) and Env28 (green) CD8 TE detected at the indicated time points within the field of a view (see
Experimental Procedures). Results are representative of at least five experiments.
(C) Quantification of the sticking fractions for Cor93 (red) and Env28 (green) CD8 TE. n = 5.
(legend continued on next page)
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Figure 2. Adhesion Molecules that Govern
Leukocyte Trafficking in Other Organs Are
Not Required for CD8 TE Accumulation in
the Liver
(A) Percentage of Cor93 CD8 TE that accumulated
within the liver 2 hr upon transfer into HBV repli-
cation-competent transgenic mice (H2bxd) that
were previously treated with anti-PSGL1, anti-
CD62L or anti-CD62E Abs relative to control (con-
trol = 100%). n = 5; results are representative of two
independent experiments. Similar results were
obtained with Env28 CD8 TE (data not shown).
(B) Percentage of Cor93 CD8 TE that accumulated
within the liver 2 hr upon transfer into HBV
replication-competent transgenic mice (H2bxd)
that were previously treated with anti-VLA-4, anti-
LFA-1 or anti-PECAM-1 Abs relative to control
(control = 100%). n =8; results are representative of
two independent experiments. Similar results were
obtained with Env28 CD8 TE (data not shown).
(C) Percentage of Cor93 CD8 TE that accumulated
within the liver 2 hr upon transfer into HBV repli-
cation-competent transgenic mice (H2bxd) that
were previously treated with anti-VAP-1 Abs rela-
tive to control (control = 100%). n = 5; results are
representative of two independent experiments.
Similar results were obtained with Env28 CD8 TE
(data not shown).
(D) Percentage of CD44/ Cor93 CD8 TE that
accumulated within the liver 2 hr upon transfer
into HBV replication-competent transgenic mice
(H2bxd) relative to WT Cor93 CD8 TE (WT = 100%).
n = 10; results are representative of two indepen-
dent experiments.
(E) Percentage of PTX-treated Cor93 CD8 TE that
accumulated within the liver 2 hr upon transfer
into HBV replication-competent transgenic mice
(H2bxd) relative to control Cor93 CD8 TE (control =
100%). n = 5; results are representative of two
independent experiments. Similar results were
obtained with Env28 CD8 TE (data not shown).
(F) Percentage of Cor93 CD8 TE that accumulated
within the liver 2 hr upon transfer into HBV replica-
tion-competent transgenic mice (H2bxd) that were
injected 24 hr earlier with 5 3 106 Env28 CD8 TE
relative to control (control = 100%). n = 5; results are
representative of two independent experiments.
(G) Percentage of PTX-treatedCor93CD8TE (relative to untreatedCor93CD8TE controls) that accumulatedwithin the liver 2 hr upon transfer intoHBV replication-
competent transgenic mice (H2bxd) that were treated 24 hr earlier with Env28 CD8 TE. n = 5; results are representative of two independent experiments.
Results are expressed as mean ± SEM.
See also Figure S1.confocal immunofluorescence analysis (Figures 3D and 3E). Dy-
namic epifluorescence IVM analysis of platelet-CD8 TE interac-
tion revealed that 30 out of 48 arrested CD8 TE (>60%) docked
onto platelets that were already adherent to liver sinusoids(D) Representative images of Cor93 (red) and Env28 (green) CD8 TE within the live
represent 50 mm and 20 mm (inset).
(E) Quantification of the localization (sinusoids versus post-sinusoidal venules) of a
when they arrested for >30 s. n = 5.
(F) Absolute number of hepatic Cor93 (red) and Env28 (green) CD8 TE recovered 2
mice (H2b, H2d or H2bxd). n = 8; results are representative of two independent ex
Results are expressed as mean ± SEM. ***p < 0.001.
See also Movie S1.(data not shown). Using reconstitution experiments and genetic
approaches to identify molecules that might mediate the capac-
ity of platelets to support early hepatic CD8 TE accumulation,
we found that platelet-derived CD44 (but not platelet-derivedr vasculature. Images are representative of at least ten experiments. Scale bars
dherent Cor93 (red) and Env28 (green) CD8 TE. Cells were defined as adherent
hr after injection from the livers of WT or HBV replication-competent transgenic
periments.
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Figure 3. Hepatic CD8 TE Accumulation Requires Platelets that Have Adhered to Sinusoidal Hyaluronan via CD44
(A) Percentage of Cor93 CD8 TE that accumulated within the liver 2 hr upon transfer into HBV replication-competent 3 mGP-Iba
null;hGP-IbaTg mice that were
previously depleted of platelets (aPLT) relative to control (control = 100%). n = 4; results are representative of three independent experiments.
(B) Quantification of the sticking fraction for Cor93 CD8 TE injected into HBV replication-competent 3 mGP-Iba
null;hGP-IbaTg mice that were platelet-depleted
(aPLT) or left untreated (control). Results are representative of three experiments.
(C) Quantification of the number of Cor93 CD8 TE that were still circulating 2 hr after transfer into HBV replication-competent3mGP-Iba
null;hGP-IbaTg mice that
were platelet-depleted (aPLT) or left untreated (control). Results are representative of three experiments.
(D) Representative confocal micrographs of the liver of a HBV replication-competent 3 mGP-Ibanull;hGP-IbaTg mouse (H2b) that was injected 2 hr earlier with
Cor93 (red) and Env28 (green) CD8 TE. Platelets are shown in blue and sinusoids in gray. To allow visualization of intravascular event and to enhance image clarity,
(legend continued on next page)
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P-selectin, CD40L, or serotonin) facilitated CD8 TE homing to the
liver (Figures 3F and S2A). Of note, CD44—expressed by CD8 TE
(data not shown) and platelets (Figure S2B)—has the capacity to
bind to hyaluronan on liver sinusoids (McDonald et al., 2008).
Accordingly, platelet adhesion to liver sinusoids occurred less
efficiently in CD44/ mice than wild-type (WT) controls (Fig-
ure S2C; note that CD44/ mice have normal blood platelet
counts and normal in vitro platelet aggregation capacity, data
not shown); moreover, in vivo blockade of CD44-hyaluronan
interaction or removal of sinusoidal hyaluronan decreased early
hepatic CD8 TE accumulation and the attendant liver disease
(Figures 3G, S2D, and S2E). Similar results (i.e., reduced hepatic
CD8 TE accumulation and reduced liver disease severity) were
obtained when CD44-hyaluronan interaction was blocked in a
different model of acute viral hepatitis (Iannacone et al., 2005)
that relies on endogenous, rather than adoptively transferred,
CD8 TE (Figures S2F and S2G). Altogether, these results indicate
that CD8 TE adhesion within liver sinusoids and the attendant
immunopathology require platelet-expressed CD44 interacting
with hyaluronan.
CD8 TE Crawl along Liver Sinusoids until Hepatocellular
Ags Are Recognized
We next took advantage of multiphoton IVM to study events that
follow the initial platelet-dependent sinusoidal CD8 TE arrest and
eventually lead to cognate recognition of hepatocellular Ag. To
this end, HBV-specific CD8 TE were infused into mice that had
been previously injected with either Ad-HBV-GFP or with ad-
eno-associated viral vectors encoding for GFP and for specific
HBV Ags (AAV-HBcAg-GFP or AAV-HBsAg-GFP), using experi-
mental conditions whereby fewer than 5% of hepatocytes are
transduced (data not shown). Dynamic imaging revealed that
CD8 TE not adjacent to Ag-expressing hepatocytes crawl up-
stream and downstream in the liver sinusoids at an average
speed of 10 mm/min (note that blood flows in liver sinusoids
at 100–400 mm/s) (Sironi et al., 2014). By contrast, CD8 TE
migrating in close proximity to Ag-expressing hepatocytes
slowed down and eventually arrested (Figures 4A and S3A–
S3E; Movie S4). To confirm that cessation of intrasinusoidal
CD8 TE crawling is dictated by proximity to HBV Ag-expressing
hepatocytes and by capacity to recognize cognate Ag, Cor93
and Env28 CD8 TE were co-transferred into a lineage of HBV
transgenic mice that express HBcAg (but not HBsAg) in 100%
of hepatocytes (Guidotti et al., 1994). While Env28 CD8 TE
crawled within liver sinusoids of HBcAg transgenic mice at anthe transparency of the sinusoidal rendering was set to 45% (left panels) and the
3 mm (left panels) and 1.5 mm (right panels).
(E) Percentage of Cor93 (red) and Env28 (green) CD8 TE that were adherent to
Ibanull;hGP-IbaTg mouse (H2b) that was injected 2 hr earlier with these cells. 300 o
representative of two independent experiments.
(F) Percentage of Cor93 CD8 TE that accumulated within the liver 2 hr upon tran
previously depleted of platelets (aPLT) and then injected with PBS, WT platelets
control (control = 100%). n = 6; results are representative of three independent e
(G) Percentage of Cor93 CD8 TE that accumulated within the liver 2 hr upon tran
previously injected with anti-CD44 Abs (clones KM81 or IM7 that either block o
uronidase (HA-ase) relative to control (control = 100%). n = 7; results are represe
Results are expressed as mean ± SEM. *p < 0.05, ***p < 0.001.
See also Figure S2 and Movies S2 and S3.average speed of 10 mm/min, the vast majority of Cor93 CD8
TE remained immotile, or moved much more slowly and had a
confinedmotility (Figures 4B–4F, S3F, and S3G; Movie S5). Alto-
gether, these observations indicate that CD8 TE exhibit an intra-
sinusoidal crawling behavior that halts when hepatocellular Ags
are recognized.
Of note, HBV Ag expression in HBcAg transgenic mice, as in
HBV replication-competent mice, is restricted to hepatocytes
(Isogawa et al., 2013); in keeping with this, only hepatocytes iso-
lated from these HBV transgenic mouse lineages presented Ag
in vitro to HBV-specific CD8 TE, in contrast to LSECs, Kupffer
cells and dendritic cells isolated from their livers or liver-draining
lymph nodes, which did not (Figure S4 and data not shown).
These results are consistent with recent reports showing that
HLA class I restricted HBV epitopes are exclusively expressed
by human hepatocytes during natural HBV infection (Ji et al.,
2012).
CD8 TE Recognize Hepatocellular Ags and Perform
Effector Functions in aDiapedesis-IndependentManner
The foregoing results suggest that CD8 TE may recognize hepa-
tocellular Ag while still in the intravascular space. To test this
hypothesis, we set up an immunofluorescence staining method
allowing the detection of Ag-recognizing (i.e., IFN-g producing)
cells with respect to their localization within the liver. Two hours
after the co-transfer of Cor93 and Env28 CD8 TE in H2
b-
restricted HBV replication-competent or HBcAg transgenic
mice, both populations were contained within the hepatic sinu-
soidal lumen but only MHC-matched Cor93 CD8 TE expressed
IFN-g (Figures 5A, S5A, and S5B; Movie S6; data not shown).
IFN-g expression by intravascular CD8 TE adjacent to hepato-
cyte expressing cognate Ag was also confirmed in WT mice
that were injected with Ad-HBV-GFP prior to Cor93 CD8 TE
transfer (Figures S5C and S5D). That CD8 TE performed effector
functions without extravasating is further indicated by the detec-
tion of apoptotic hepatocytes preferentially juxtaposed to intra-
vascular MHC-matched—rather than MHC-mismatched—CD8
TE (Figure 5B; Movie S6; quantification in Figure S6). Confocal
3D reconstructions of these experiments occasionally revealed
the presence of small CD8 TE protrusions appearing to penetrate
the sinusoidal wall in order to gain contact with underlying hepa-
tocytes (Figure 5B;Movie S6). Analysis of the hepatic localization
of CD8 TE in transgenic and nontransgenic MHC-matched and
MHC-mismatched recipients at 2 and 4 hr after CD8 TE transfer
revealed that only CD8 TE capable of recognizing Ag eventuallytransparency of the cell rendering to 48% (right panels). Scale bars represent
endogenous platelets in the liver of a HBV replication-competent 3 mGP-
f each cell type from 30 random 403 fields of view were analyzed. Results are
sfer into HBV replication-competent 3 mGP-Ibanull;hGP-IbaTg mice that were
, P-selectin/ platelets, CD40L/ platelets, or CD44/ platelets relative to
xperiments. For the role of platelet-derived serotonin see Figure S2.
sfer into HBV replication-competent x mGP-Ibanull;hGP-IbaTg mice that were
r not the capacity of CD44 to bind to hyaluronan [HA], respectively) or hyal-
ntative of two independent experiments.
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Figure 4. CD8 TE Crawl along Liver Sinusoids until Hepatocellular Ags Are Recognized
(A) Intrasinusoidal crawling of CD8 TE, visualized by multiphoton IVM (still image from Movie S4) in the liver of a WT mouse that was injected with Ad-HBV-GFP
2 days prior to Cor93 CD8 TE transfer. The movie was recorded1 hr after Cor93 CD8 TE transfer. Red lines denote tracks of individual Cor93 CD8 TE. Sinusoids
are in gray. Scale bar represents 50 mm. Similar results were obtained when Env28 CD8 TE were transferred into Ad-HBV-GFP-injected mice or when Cor93 or
Env28 CD8 TE were transferred into WT mice previously injected with AAV-HBcAg-GFP or AAV-HBsAg-GFP, respectively (data not shown).
(B) Intrasinusoidal crawling of CD8 TE, visualized by multiphoton IVM (still image from Movie S5) in the liver of a HBcAg transgenic mouse (H2
b) that was injected
with H2b-restricted Cor93 (red) and H2d-restricted Env28 (green) CD8 TE. Red and green lines denote tracks of individual Cor93 and Env28 CD8 TE, respectively.
Sinusoids are in gray and hepatocellular nuclei are in blue. Scale bar represents 50 mm.
(legend continued on next page)
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extravasate (Figures S7A–S7C). These observations, coupled
with the notion that the ratio between intravascular and extravas-
cular CD8 TE performing effector functions (i.e., expressing IFN-
g or triggering hepatocellular apoptosis) decreases over time
(Figures S7D and S7E), indicate that extravasation follows rather
than precedes Ag recognition. Together, the above results indi-
cate that CD8 TE do not need to extravasate in order to recognize
hepatocellular Ags and to perform effector functions.
CD8 TE Recognize Hepatocellular Ags through
Fenestrations in Liver Sinusoidal Endothelial Cells
The above-mentioned results and the unique anatomy of the liver
microvasculature suggest that CD8 TE cellular protrusions might
reach underlying hepatocytes through anatomical discontinu-
ities in the hepatic sinusoid created by fenestrae that penetrate
the endothelial cell lining. To test this hypothesis, we established
a correlative technique that combines the specificity of 3D
confocal fluorescence microscopy with the resolution of trans-
mission electron tomography; this was carried out on liver sec-
tions from HBcAg transgenic mice whose LSEC are fluorescent
(see Experimental Procedures). While confirming at higher reso-
lution that CD8 TE protrusions penetrate the sinusoidal wall, we
found that these structures correspond to cytoplasmic CD8 TE
extensions that protrude through the LSEC fenestrae and con-
tact the hepatocytemembrane over relatively large surface areas
(Figures 5C and 5D; Movie S7). Although the fixation procedure
of this correlative technique does not permit Ab staining (thus
it cannot detect Ag recognition markers), these results are
compatible with the formation of an immunological synapse be-
tween intravascular CD8 TE and hepatocytes. The notion that
CD8 TE extend cytoplasmic protrusions penetrating the sinusoi-
dal barrier of WT mice as well (data not shown) suggests that
contacts with sub-sinusoidal hepatocytes might be the mecha-
nism whereby CD8 TE crawling intravascularly probe the liver
for the presence of hepatocellular Ag.
To test the biological significance of CD8 TE-mediated
Ag recognition through sinusoidal fenestrae, HBV replication-
competent transgenic mice were chronically exposed to low
doses of arsenite (Straub et al., 2007), a treatment that reduces
liver porosity (i.e., number and size of sinusoidal endothelial cell
fenestrae) recapitulating the sinusoidal defenestration that char-
acterizes liver fibrosis (Friedman, 2004). Arsenite treatment
decreased liver porosity by 5-fold (Figures 6A–6C) without
affecting neither hepatic HBV Ag expression nor the capacity
of hepatocytes to present Ag to CD8 TE in vitro (data not shown).
This same treatment did not alter the hepatic homing of CD8 TE,
which is platelet-dependent, but it reduced their in vivo Ag
recognition capacity, as evidenced by the reduction of both
IFN-g expression and sALT elevation (Figures 6D–6J). To rule
out off-target effects of arsenite treatment, we infected arse-(C) Still image (large left panel) and time lapse recording (small right panels) in th
and Env28 (green) CD8 TE. Red and green lines denote tracks of individual Co
minutes:seconds. Scale bar represents 15 mm (left) and 10 mm (right).
(D–F) Mean speed (D), displacement (E), and straightness (F) (see Experimental P
HBcAg transgenic mouse (H2b). Data are representative of two independent exp
Results are expressed as mean ± SEM. ***p < 0.001.
See also Figures S3 and S4 and Movies S4 and S5.nite-treated mice with LCMV, a virus whose tropism in the liver
is mostly restricted to intravascular Kupffer cells (Guidotti
et al., 1999) and where, therefore, subsequently transferred
LCMV-specific CD8 TE should recognize infected cells indepen-
dent of contacts through sinusoidal endothelial fenestrae.
Indeed, arsenite exposure impacted neither the homing nor the
Ag-recognition capacity of LCMV-specific CD8 TE (Figures 6K
and 6L).
Next, we evaluated whether the deposition of extracellular
matrix in the space of Disse—a process known as liver capillari-
zation, which creates a physical barrier between sinusoidal fe-
nestrae and hepatocellular membranes and is frequently found
in fibrotic livers (Friedman, 2004)—could also limit Ag recognition
by intravascular CD8 TE. To this end, we transferred HBV-spe-
cific CD8 TE to HBV replication-competent transgenic mice
with liver fibrosis as a consequence of chronic exposure to car-
bon tetrachloride (Figures 7A–7C). This treatment did not alter
the capacity of CD8 TE to home to the liver, while significantly
impaired CD8 TE ability to recognize Ag on hepatocytes but
not on intravascular Kupffer cells (Figures 7D–7H).
Altogether, these results indicate that CD8 TE recognize hepa-
tocellular Ags through sinusoidal endothelial fenestrations and
suggest a mechanism whereby liver fibrosis reduces T cell im-
mune-surveillance toward infected or transformed hepatocytes.
DISCUSSION
In this study, we coupled advanced imaging techniques and
models of HBV pathogenesis to reveal previously unappreciated
determinants that regulate the migration, Ag recognition, and
effector function of CD8 TE within the liver. In contrast to most
other organs—where CD8 TE arrest is mainly restricted to post-
capillary venules and promoted by inflammation (von Andrian
and Mackay, 2000)—CD8 TE circulating through the liver initially
arrest within sinusoids and they do so independently of selec-
tins, Gai-coupled chemokine receptors, b2- and a4-integrins,
PECAM-1, and VAP-1. Furthermore, sinusoidal arrest and early
accumulation of CD8 TE occurs independently of their capacity
to recognize hepatocellular Ag.
We previously used similar models of HBV pathogenesis to
show that platelets are involved in hepatic CD8 TE accumulation
occurring 1–2 days post transfer (Iannacone et al., 2005), but the
molecular mechanisms and spatiotemporal dynamics underly-
ing these observations have remained elusive. Herein, we
extended these observations by showing that (1) platelets
adhere to LSEC even under steady-state conditions, leading to
the transient formation of small intrasinusoidal aggregates on
LSECs; (2) this process is mediated by platelet-expressed
CD44 interacting with LSEC hyaluronan; and (3) intrasinusoidal
platelet aggregates function as preferential docking sites fore liver of a HBcAg transgenic mouse (H2b) that was injected with Cor93 (red)
r93 and Env28 CD8 TE, respectively. Sinusoids are in gray. Elapsed time in
rocedures) of individual Cor93 (red) and Env28 (green) CD8 TE in the liver of a
eriments.
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Figure 5. CD8 TE Recognize Hepatocellular Ags and Perform Effector Functions in a Diapedesis-Independent Manner
(A) Representative confocal micrographs of the liver of a HBV replication-competent transgenic mouse (H2b) that was injected 2 hr earlier with Cor93 (red) and
Env28 (green) CD8 TE. Sinusoids are shown in gray and IFN-g in yellow. To allow visualization of intravascular events and to enhance image clarity, the trans-
parency of the sinusoidal rendering in the right panel was set to 70% and that of T cells to 60%. Scale bars represent 4 mm. See also Movie S6 and Figure S5.
Similar results were obtained in similarly treated HBcAg transgenic mice (data not shown).
(B) Representative confocal micrographs of the liver of a HBV replication-competent transgenicmouse (H2b) that was injected 2 hr earlier with Cor93 CD8 TE (red).
Sinusoids are shown in gray and caspase 3 in brown. To allow visualization of intravascular events and to enhance image clarity, the transparency of the si-
nusoidal rendering in the right panel was set to 50%. Scale bars represent 5 mm. See alsoMovie S6 and Figure S6. Similar results were obtained in similarly treated
HBcAg transgenic mice (data not shown).
(legend continued on next page)
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circulating CD8 TE. Other platelet molecules that had been
previously implicated in the cross-talk between platelets and
adaptive immunity, such asCD40L (Iannacone et al., 2008) or se-
rotonin (Lang et al., 2008) were shown to be dispensable for
these processes. Notably, platelets have been shown to form in-
trasinusoidal aggregates on the surface of bacterially infected
Kupffer cells, possibly as a pathogen-trapping mechanism pro-
moting immune-mediated clearance (Wong et al., 2013). In
contrast to this study, we saw no evidence for a preferential for-
mation of platelet aggregates on Kupffer cells in our system (data
not shown), where Kupffer cells are neither infected with bacteria
nor targeted by CD8 TE. These results, together with the notion
that Kupffer cell depletion does not affect hepatic CD8 TE accu-
mulation in these mouse models (Sitia et al., 2011), indicate that
platelet-Kupffer cell interaction does not play a role in the hepatic
homing of CD8 TE targeting hepatocellular Ags.
It is noteworthy that experiments using anti-GP-Iba Abs to
deplete circulating platelets by roughly 50-fold (reducing normal
platelet counts from 106 platelets/ml to 2 3 104 platelets/ml)
decreased the early hepatic accumulation of CD8 TE only 2-
fold. These results suggest that either the number of circulating
platelets vastly exceeds the number required to efficiently arrest
CD8 TE in the liver or that a fraction of CD8 TE home to the liver
independently of platelets. Although the failure to further reduce
hepatic CD8 TE accumulation by treating platelet-depleted ani-
mals with CD44 blocking Abs supports the latter hypothesis,
future studies are needed to settle this issue definitively.
Although our data have unambiguously identified the molecu-
lar interaction by which platelets adhere to LSEC, the mecha-
nism(s) supporting CD8 TE docking onto platelet aggregates
remains unexplained. Of note, platelets possess a large array
of surface molecules mediating adhesion to endothelial cells,
and, among these, only P-selectin has a known ligand (i.e.,
PSGL-1) expressed also by CD8 TE (Borges et al., 1997). As pas-
sive PSGL-1 neutralization or reconstitution with P-selectin-defi-
cient platelets did not alter the capacity of CD8 TE to accumulate
intrahepatically, it appears that the interaction between P-selec-
tin on platelets and PSGL-1 on CD8 TE is not operative in our
system. Whether other constitutively expressed or activation-
induced platelet molecules directly or indirectly (via the forma-
tion of molecular bridges with CD8 TE ligands) contribute to the
process of CD8 TE docking onto platelet aggregates remains
to be determined. An attractive alternative hypothesis, which is
currently under investigation, is that intrasinusoidal platelet ag-
gregates alter local flow dynamics in ways that force CD8 TE to
slowdown and then engage platelets and/or LSEC via non-cova-
lent interactions.
Following the initial interaction with platelets, CD8 TE were
shown to crawl along liver sinusoids independently of blood di-
rection and at a speed that was 500- to 1,000-fold slower than(C) Correlative confocal and transmission electron microscopy of the liver of an H
(see Experimental Procedures) that was injected 30 min earlier with Cor93 CD8
respectively) with the electron micrograph of the same section. Right: electron m
(D) Transmission electron tomograms of five selected serial slices from the area d
middle section. Cor93 CD8 TE and LSEC are indicated by the red and green over
tomographic reconstruction of 289 sections with a 1.95 nm z-step.
See also Figures S5, S6, and S7 and Movies S6 and S7.sinusoidal flow (Sironi et al., 2014). This multi-directional intrasi-
nusoidal crawling behavior is reminiscent of what has been
observed for CD1d-restricted NKT cells patrolling the liver
microvasculature (Geissmann et al., 2005). While the molecular
mechanisms mediating CD8 TE crawling are unknown, prelimi-
nary data show that chemokine cues might not be involved
in this process (unpublished data). Whether hepatic CD8 TE
crawl along physical structures—as described for naive T cells
migrating along the fibroblastic reticular cell network in the
T cell area of lymph nodes (Baje´noff et al., 2006) or for effector
T cells migrating along the myeloid scaffold delineating hepatic
granulomas (Egen et al., 2008)—or whether noradrenergic
neurotransmitters from sympathetic nerves can also modulate
intrasinusoidal CD8 TE motility—as described for intrasinu-
soidal hepatic NKT cells (Wong et al., 2011)—remains to be
determined.
Importantly, our data show that the intrasinusoidal crawling
behavior represents a form of immune surveillance, since it oc-
curs independently of the presence of cognate Ag and it ceases
following hepatocellular Ag recognition. Indeed, virus-specific
CD8 TE were shown to recognize hepatocellular Ags and to
perform pathogenic functions (i.e., they produced IFN-g and
they killed HBV-expressing hepatocytes) while still in the intra-
vascular space. These processes were mediated by the exten-
sion of cellular protrusions through sinusoidal endothelial cell
fenestrae by CD8 TE, producing contact sites with the hepato-
cyte membrane that are compatible with the establishment of
an immunological synapse (Dustin and Groves, 2012). Of note,
this Ag probing activity by intravascular CD8 TE would require
the formation and retraction of cellular protrusions, events that
might seem at odds with average CD8 TE migration rates of
10 mm/min. The high variability among CD8 TE velocities (be-
tween 1 and up to 30 mm/min, see Figure 4D) is compatible
with the hypothesis that slower cells aremore active in extending
and retracting trans-endothelial protrusions than faster-moving
ones. The notion that circulating leukocytes can interact with he-
patocytes through endothelial fenestrations has been proposed
in previous studies (Ando et al., 1994; Geissmann et al., 2005;
Warren et al., 2006). Our results revealed that this process
has functional significance, as reducing sinusoidal porosity or
creating a physical barrier between sinusoidal fenestrae and he-
patocellular membranes inhibited hepatocellular Ag recognition
by CD8 TE. These results also suggest a potential mechanism
whereby liver fibrosis (a condition promoting both sinusoidal
defenestration and capillarization) might reduce CD8 TE immune
surveillance toward infected or transformed hepatocytes and, in
the latter case, favor the development and progression of hepa-
tocellular carcinoma.
Another novel finding from our studies is that CD8 TE extrav-
asation from the liver microcirculation follows, rather thanBcAg transgenic mouse whose LSEC express membrane-targeted tdTomato
TE. Left: overlay of the Cor93 CD8 TE and LSEC fluorescence (red and green,
icrograph alone. Scale bars represent 2 mm.
elineated by the red inset in (C). The numbers indicate the z-distance from the
lay, respectively. Scale bars represent 500 nm. See Movie S7 for the complete
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Figure 6. Reducing Sinusoidal Porosity Limits Hepatocellular Ag Recognition by CD8 TE
(A and B) Representative scanning electron micrographs from liver sections of control (A) or arsenite-treated (B) HBV replication-competent transgenic mice
(H2bxd) mice. Yellow dotted lines denote sinusoidal edges. Scale bars represent 1 mm.
(C) Porosity (the percentage of liver endothelial surface area occupied by fenestrae) was measured in control and arsenite-treated mice. n = 3; results are
representative of two independent experiments.
(D) Percentage of Cor93 CD8 TE that accumulated within the liver 2 hr upon transfer into HBV replication-competent transgenic mice (H2
bxd) that were previously
treated with arsenite relative to control (control = 100%). n = 20; results are representative of two independent experiments. Similar results were obtained with
Env28 CD8 TE (data not shown).
(E) Total hepatic RNA from the same mice described in (D) was analyzed for the expression of IFN-g by qPCR. Results are expressed as fold induction (f.i.) over
HBV replication-competent transgenic mice injected with PBS, after normalization to the housekeeping gene GAPDH.
(legend continued on next page)
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precedes, hepatocellular Ag recognition and effector function.
The fate of extravasated CD8 TE remains ill defined. One
possibility is that they invade hepatocytes, enter endosomal/
lysosomal compartments and are degraded, a process of
suicidal emperipolesis that was recently described for naive
CD8+ T cells undergoing primary activation in the liver (Bens-
eler et al., 2011). We are attracted by the hypothesis that
CD8 TE extravasation into the liver parenchyma (whether
through emperipolesis or other yet undefined mechanisms)
might actually represent a way to limit Ag recognition and,
therefore, to regulate excessive liver damage caused by CD8
TE. This concept is supported by the notion that hepatocellular
MHC-I expression is polarized and localized predominantly to
the portion of the basolateral membrane facing the sinusoidal
lumen (Warren et al., 2006), so that MHC-I-peptide complexes
might be less accessible to CD8 TE residing in extravascular
spaces.
In summary, the data presented here reveal novel dynamic de-
terminants regulating trafficking and effector function of CD8 TE
after hepatocellular Ag recognition. This is particularly relevant
for the pathogenesis of viral infections such as those caused
by HBV and HCV, noncytopathic pathogens that replicate selec-
tively in the hepatocyte and cause acute or chronic liver disease
that are triggered by virus-specific CD8 TE (Guidotti and Chisari,
2006). By extension, it is conceivable that similar mechanisms
may also be operative for bacterial and parasitic infections that
target hepatocytes.
EXPERIMENTAL PROCEDURES
Mice
Mice were obtained from various sources and maintained in SPF conditions.
All experimental animal procedures were approved by the Institutional Animal
Committee of the San Raffaele Scientific Institute. For details on mouse lines
and BM chimera generation, see the Extended Experimental Procedures.
Viruses and Vectors
For details on adenoviral vectors, adeno-associated viruses and LCMV, see
the Extended Experimental Procedures. All infectious work was performed
in designated BSL-2 or BSL-3 workspaces, in accordance with institutional
guidelines.
Generation of Effector CD8+ T Cells and Adoptive Transfer
In vitro generation of CD8+ T cells (CD8 TE) was performed basically as
described (Manjunath et al., 2001). A total of 107 cells of each cell type were
injected intravenously (i.v.) into recipient animals. In imaging experiments,
CD8 TE were labeled with 2.5 mM CMFDA, 2.5 mM CFSE, 7.5 mM CMTPX,
10 mM CMTMR, or 2.5 mM BODIPY 630/650-X (Life Technologies) for 20 min
at 37C in plain RPMI prior to adoptive transfer. For details, see the Extended
Experimental Procedures.(F) ALT activity measured in the serum of the same mice described in (D).
(G and H) Representative confocal micrographs from the same mice described
Arrowheads denote IFN-g+ cells. Scale bars represent 20 mm.
(I) The percentage of Cor93 CD8 TE that stained positive for IFN-g was quantifie
(J) IFN-g mean fluorescence intensity (MFI) of Cor93 CD8 TE was quantified in liv
(K) Percentage of GP33 CD8 TE that accumulated within the liver 2 hr upon transfe
control (control = 100%). n = 5; results are representative of two independent ex
(L) Total hepatic RNA from the same mice described in (K) was analyzed for the e
LCMV-infected mice injected with PBS, after normalization to the housekeeping
Results are expressed as mean ± SEM. **p < 0.01, ***p < 0.001.Blocking Abs and Hyaluronidase Treatment
The following blocking Abs were injected i.v. 2 hr prior to T cell transfer: anti-
PSGL-1 (clone 4RA10; BioXCell; 200 mg/mouse), anti-CD62L (clone MEL-14;
BioXCell; 100 mg/mouse), anti-CD62E (clone 10E9.6; BD PharMingen;
100 mg/mouse), anti-VLA-4 (clone PS/2; BioXCell; 100 mg/mouse), anti-
LFA-1 (clone M17/4; BioXCell; 100 mg/mouse and clone GAME46; BD
PharMingen; 25 mg/mouse), anti-PECAM-1 (clone MEC13.3; BioLegend;
100 mg/mouse), anti-VAP-1 (80 mg of clone 7-88 + 80 mg of clone 7-106/mouse,
both provided by S. Jalkanen), anti-CD44 (clone KM81, blocking CD44 binding
to hyaluronan [Zheng et al., 1995]; Cedarlane; 20 mg/mouse), anti-CD44 (clone
IM7, not interfering with CD44 binding to hyaluronan [Zheng et al., 1995];
BioXCell; 100 mg/mouse). In indicated experiments mice were injected intra-
peritoneally (i.p.) with 20 U/g hyaluronidase type-IV (Sigma-Aldrich), as
described (Johnsson et al., 1999).
Env28 CD8 TE-Mediated Induction of Liver Inflammation
In order to increase the hepatic expression of selectins, integrin ligands and
chemokines (experiments described in Figures 2F, 2G, and S1), HBV replica-
tion-competent transgenic mice were injected i.v. with 5 3 106 Env28 CD8 TE
24 hr prior to the injection of 107 Cor93 CD8 TE.
Treatment with Pertussis Toxin and Chemotaxis Assay
The role of Gai signaling was assessed by incubating CD8 TE (10
7 cells/ml) for
2 hr at 37C with 100 ng/ml pertussis toxin (Merck). For details on chemotaxis
assay see the Extended Experimental Procedures.
Depletion and Transfusion of Platelets
HBV replication-competent x mGP-Ibanull;hGP-IbaTg mice were injected i.v.
with 80 mg of clone LJ-P3 (a monoclonal Ab that recognizes the platelet-
specific humanGP-Iba) at least 3 hr prior to further experimental manipulation,
as described (Iannacone et al., 2008). Platelet transfusion was performed
as described (Iannacone et al., 2008), with each mouse receiving a single i.v.
injection of 6 3 108 platelets.
Treatment with Sodium Arsenite or Carbon Tetrachloride
In indicated experiments, mice were treated with sodium arsenite (250 ppb in
drinking water ad libitum) for 10 weeks. In other experiments mice were fed by
oral gavage with a solution of carbon tetrachloride (CCl4) in peanut oil (Sigma-
Aldrich) at a final dose of 0.7 mg/g of body weight. CCl4 was administered
twice a week for 12 weeks, after which the treatment was suspended for a
washout period of 4 weeks.
Cell Isolation and Flow Cytometry
Single-cell suspensions of livers, spleens, and lymph nodes were generated
as described (Iannacone et al., 2005; Tonti et al., 2013). For details on flow
cytometric analyses see the Extended Experimental Procedures.
Isolation of Primary Hepatocytes, LSEC, Kupffer Cells, Intrahepatic
Dendritic Cells, and Dendritic Cells from Liver-Draining Lymph
Nodes
Primary hepatocytes, LSEC, Kupffer cells, and dendritic cells were isolated
essentially as described (Isogawa et al., 2013). Hepatic lymph node dendritic
cells were isolated by positive selection using biotinylated CD11c and strepta-
vidinMagnetic Particles (BDBiosciences). For details see the Extended Exper-
imental Procedures.in (D). Cor93 CD8 TE are shown in red, sinusoids in gray and IFN-g in yellow.
d in liver sections from the same mice described in (D). n = 90.
er sections from the same mice described in (D). n = 90.
r into LCMV-infected mice that were previously treated with arsenite, relative to
periments.
xpression of IFN-g by qPCR. Results are expressed as fold induction (f.i.) over
gene GAPDH.
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Figure 7. Liver Fibrosis Limits Hepatocellular Ag Recognition by CD8 TE
(A and B) Representative Sirius Red (left) or transmission electron (right) micrographs from liver sections of control (A) or carbon tetrachloride (CCl4)-treated (B)
HBV replication-competent transgenic mice. Sirius Red staining is shown in red. Scale bars represent 100 mm (Sirius Red) and 1.5 mm (transmission electron
micrographs). Red and yellow dotted lines denote LSEC and the hepatocyte body, respectively. SD, space of Disse; H, hepatocyte.
(C) Quantification of Sirius red staining in HBV replication-competent transgenic mice that were treated or not with CCl4. n = 3; results are representative of two
independent experiments.
(D) Percentage of Cor93 CD8 TE that accumulated within the liver 2 hr upon transfer into HBV replication-competent transgenic mice (H2
bxd) that were previously
treated with carbon tetrachloride (CCl4) relative to control (control = 100%). n = 15; results are representative of two independent experiments.
(legend continued on next page)
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Imaging Studies
For details on histochemistry, confocal immunofluorescence histology, intra-
vital epifluorescence, and multiphoton microscopy, electron microscopy,
and correlative light and electron tomography, see the Extended Experimental
Procedures.
DNA, RNA, and Biochemical Analyses
For details on molecular and biochemical analyses, see the Extended Exper-
imental Procedures.
Statistical Analyses
Results are expressed as mean ± SEM. All statistical analyses were performed
in Prism 5 (GraphPad Software). Means between two groups were compared
with two-tailed t test. Means among three or more groups were compared with
one-way or two-way ANOVA with Bonferroni post-test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and seven movies and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2015.03.005.
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